Annual Cash & Cash Equivalents
Summary
- Current Value
- As of today, NAMS annual cash & cash equivalents is $771.74M, up +126.68% on
- Historical Performance
- NAMS annual cash & cash equivalents is up +1183.84% over the past 3 years, and up +7881.87% over the past 5 years
- All-Time High Comparison
- NAMS annual cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- NAMS annual cash & cash equivalents is +126.68% above its 3-year low of $340.45M reached on
- Sector Comparison
- NAMS annual cash & cash equivalents is higher than 92.03% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $771.74M | +126.7% | +1183.8% | +7881.9% | +7881.9% | |
| Quarterly Cash & Cash Equivalents | $704.25M | +66.6% | +10000.0% | +10000.0% | +10000.0% | |
| Price | $35.80 | +40.1% | +202.3% | – | – | |
| Annual Current Assets | $863.41M | +149.0% | +1195.3% | +7514.6% | +7514.6% | |
| Annual Total Liabilities | $107.12M | +82.5% | +1262.0% | +763.3% | +763.3% | |
| Annual Working Capital | $756.50M | +154.8% | +10000.0% | +10000.0% | +10000.0% | |
| Annual Net Income | -$241.60M | -36.5% | -5881.9% | -10000.0% | -10000.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $771.74M | at high | |
| 5Y | $771.74M | at high | |
| All | $771.74M | at high |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $340.45M | +126.7% | |
| 5Y | $9.67M | N/A | +7881.9% |
| All | $9.67M | +7881.9% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $771.74M | +126.7% | |
| $340.45M | -27.2% | |
| $467.73M | +678.1% |
| Year | Value | Change |
|---|---|---|
| $60.11M | +521.7% | |
| $9.67M | - |
FAQ
What is the current annual cash & cash equivalents of NAMS?
As of today, NAMS annual cash & cash equivalents is $771.74M
What is 1-year change in NAMS annual cash & cash equivalents?
NAMS annual cash & cash equivalents is up +126.68% year-over-year
What is 3-year change in NAMS annual cash & cash equivalents?
NAMS annual cash & cash equivalents is up +1183.84% over the past 3 years
How far is NAMS annual cash & cash equivalents from its all-time high?
NAMS annual cash & cash equivalents is currently at its all-time high
How does NAMS annual cash & cash equivalents rank versus sector peers?
NAMS annual cash & cash equivalents is higher than 92.03% of companies in Healthcare sector
When is NAMS next annual earnings release?
The next annual earnings release for NAMS is on
Quarterly Cash & Cash Equivalents
Summary
- Current Value
- As of today, NAMS quarterly cash & cash equivalents is $704.25M, down -4.72% on
- Historical Performance
- NAMS quarterly cash & cash equivalents is up +66.60% year-over-year, and up +187451.00% over the past 3 years
- All-Time High Comparison
- NAMS quarterly cash & cash equivalents is currently -15.58% below its historical high of $834.19M set on
- 3-Year Low Comparison
- NAMS quarterly cash & cash equivalents is +187451.00% above its 3-year low of $375.50K reached on an earlier date
- Sector Comparison
- NAMS quarterly cash & cash equivalents is higher than 89.68% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $704.25M | -4.7% | +66.6% | +10000.0% | +10000.0% | |
| Annual Cash & Cash Equivalents | $771.74M | – | +126.7% | +1183.8% | +7881.9% | |
| Price | $35.80 | +8.9% | +40.1% | +202.3% | – | |
| Quarterly Current Assets | $732.33M | -4.9% | +67.3% | +10000.0% | +10000.0% | |
| Quarterly Total Liabilities | $58.36M | +59.4% | -3.3% | +377.8% | +370.3% | |
| Quarterly Working Capital | $674.06M | -8.1% | +70.0% | +10000.0% | +10000.0% | |
| Quarterly Net Income | -$72.01M | -314.7% | -332.5% | -1406.3% | -10000.0% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $834.19M | N/A | -15.6% |
| 3Y | $834.19M | -15.6% | |
| 5Y | $834.19M | -15.6% | |
| All | $834.19M | -15.6% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $704.25M | at low | |
| 3Y | $375.50K | N/A | >+9999.0% |
| 5Y | $375.50K | >+9999.0% | |
| All | $375.50K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
| Month | Value | Change |
|---|---|---|
| $704.25M | -4.7% | |
| $739.16M | -8.6% | |
| $808.48M | -3.1% | |
| $834.19M | +97.3% | |
| $422.73M | -1.9% |
| Month | Value | Change |
|---|---|---|
| $430.71M | -10.5% | |
| $481.15M | >+9,900.0% | |
| $375.50K | -39.0% | |
| $615.40K | -21.9% | |
| $788.00K | - |
FAQ
What is the current quarterly cash & cash equivalents of NAMS?
As of today, NAMS quarterly cash & cash equivalents is $704.25M
What is NAMS quarterly cash & cash equivalents most recent change?
NAMS quarterly cash & cash equivalents was down -4.72% on September 30, 2025
What is 1-year change in NAMS quarterly cash & cash equivalents?
NAMS quarterly cash & cash equivalents is up +66.60% year-over-year
How far is NAMS quarterly cash & cash equivalents from its all-time high?
NAMS quarterly cash & cash equivalents is currently -15.58% below its historical high of $834.19M set on December 31, 2024
How does NAMS quarterly cash & cash equivalents rank versus sector peers?
NAMS quarterly cash & cash equivalents is higher than 89.68% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
Cash and Cash Equivalents Formula
Data Sources & References
- NAMS Official Website www.newamsterdampharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
- NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
- NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams
